OpenLB
Open Library of Bioscience
Advanced Search
Nature biotechnology
Jul, 2003;21 (7): 718.

Industry reneges on postmarketing trial commitments.

Aaron Bouchie
Author Information
PMID: 12833074 DOI: 10.1038/nbt0703-718

Abstract

No abstract text available.

MeSH Term

Clinical Trials, Phase IV as Topic
Drug Approval
Drug Industry
Guideline Adherence
Product Surveillance, Postmarketing
Social Responsibility
United States
News

Word Cloud

Created with Highcharts 10.0.0Industryrenegespostmarketingtrialcommitments

Similar Articles

Cited By (1)